Neuroendocrine tumour management: a team approach
- 1 January 2005
- journal article
- review article
- Published by Mark Allen Group in British Journal of Hospital Medicine
- Vol. 66 (1) , 37-42
- https://doi.org/10.12968/hmed.2005.66.1.17534
Abstract
This article gives an overview of neuroendocrine tumours of the gut, liver and pancreas and will make the case for a multidisciplinary approach to management.Keywords
This publication has 25 references indexed in Scilit:
- Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison SyndromeMedicine, 2004
- Carcinoid tumour of the appendixBritish Journal of Surgery, 2003
- Prospective, Randomized, Multicenter Trial on the Antiproliferative Effect of Lanreotide, Interferon Alfa, and Their Combination for Therapy of Metastatic Neuroendocrine Gastroenteropancreatic Tumors—The International Lanreotide and Interferon Alfa Study GroupJournal of Clinical Oncology, 2003
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003
- Hepatic neuroendocrine metastases: does intervention alter outcomes?1Journal of the American College of Surgeons, 2000
- Clinical Spectrum of Hyperglucagonemia Associated With Malignant Neuroendocrine TumorsMayo Clinic Proceedings, 1996
- Clinical Manifestations of Carcinoid DiseaseWorld Journal of Surgery, 1996
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndromeCancer, 1991
- Rectal carcinoids as tumors of the hindgut endocrine cellsThe American Journal of Surgical Pathology, 1982